A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.

Publication Type:

Journal Article

Authors:

Jones, Robin L; Bendell, Johanna C; Smith, David C; Diefenbach, Konstanze; Lettieri, John; Boix, Oliver; Lockhart, A Craig; O'Bryant, Cindy; Moore, Kathleen N

Source:

Cancer chemotherapy and pharmacology (2015)

Abstract:

To characterize the cardiovascular safety profile of regorafenib in patients with advanced cancer.